CC
Checkpoint Capital Portfolio holdings
AUM
$215M
This Quarter Return
+23.5%
1 Year Return
+27.24%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$202M
AUM Growth
+$202M
(+22%)
Cap. Flow
+$3.7M
Cap. Flow
% of AUM
1.84%
Top 10 Holdings %
Top 10 Hldgs %
95.37%
Holding
19
New
3
Increased
6
Reduced
6
Closed
3
Top Buys
| 1 |
Cytokinetics
CYTK
|
$14.6M |
| 2 |
Phathom Pharmaceuticals
PHAT
|
$11.4M |
| 3 |
argenx
ARGX
|
$5.61M |
| 4 |
TScan Therapeutics
TCRX
|
$4.11M |
| 5 |
Stoke Therapeutics
STOK
|
$1.94M |
Top Sells
| 1 |
Rhythm Pharmaceuticals
RYTM
|
$13.6M |
| 2 |
Corcept Therapeutics
CORT
|
$7.95M |
| 3 |
Axsome Therapeutics
AXSM
|
$7.29M |
| 4 |
Protagonist Therapeutics
PTGX
|
$5.18M |
| 5 |
Kymera Therapeutics
KYMR
|
$2.45M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
argenx
ARGX
$43.6B
| $50.1M | 24.88% |
92,500
+10,350
| +13% | +$5.61M |
|
|
2
Rhythm Pharmaceuticals
RYTM
$6.85B
| $34.8M | 17.24% |
663,381
-258,719
| -28% | -$13.6M |
|
|
3
Phathom Pharmaceuticals
PHAT
$864M
| $27.2M | 13.49% |
1,504,307
+629,307
| +72% | +$11.4M |
|
|
4
Cytokinetics
CYTK
$4.23B
| $24.6M | 12.23% |
466,813
+276,813
| +146% | +$14.6M |
|
|
5
Axsome Therapeutics
AXSM
$6.05B
| $18.8M | 9.35% |
209,632
-81,140
| -28% | -$7.29M |
|
|
AVDL
6
Avadel Pharmaceuticals
AVDL
$1.43B
| $14.4M | 7.16% |
1,100,000
-38,178
| -3% | -$501K |
|
|
7
Protagonist Therapeutics
PTGX
$3.67B
| $10.8M | 5.36% |
240,000
-115,000
| -32% | -$5.18M |
|
8
Pliant Therapeutics
PLRX
$101M
| $4.26M | 2.11% |
380,000
+147,800
| +64% | +$1.66M |
|
|
9
TScan Therapeutics
TCRX
$102M
| $4.11M | 2.04% |
+825,341
| New | +$4.11M |
|
|
ATYR
10
aTyr Pharma
ATYR
$527M
| $3.06M | 1.52% |
1,736,477
-210,000
| -11% | -$370K |
|
11
Soleno Therapeutics
SLNO
$3.6B
| $2.93M | 1.45% |
57,983
+38,288
| +194% | +$1.93M |
|
12
Cidara Therapeutics
CDTX
$1.66B
| $1.96M | 0.97% |
182,426
+37,009
| +25% | +$398K |
|
|
13
Stoke Therapeutics
STOK
$1.08B
| $1.94M | 0.96% |
+157,514
| New | +$1.94M |
|
14
Disc Medicine
IRON
$2.07B
| $1.26M | 0.62% |
+25,543
| New | +$1.26M |
|
15
Trevi Therapeutics
TRVI
$883M
| $835K | 0.41% |
250,000
-250,089
| -50% | -$835K |
|
|
ALLK
16
DELISTED
Allakos
ALLK
| $425K | 0.21% |
649,957
| – | – |
|
|
17
Corcept Therapeutics
CORT
$7.35B
| – | – |
-244,750
| Closed | -$7.95M |
|
|
18
Kymera Therapeutics
KYMR
$2.95B
| – | – |
-82,000
| Closed | -$2.45M |
|
19
Applied Therapeutics
APLT
$71M
| – | – |
-227,470
| Closed | -$1.06M |
|